Details

Autor(en) / Beteiligte

• Dong, Zhen
• Zhang, Guoxin
• Qu, Meng
• Gimple, Ryan C
• Wu, Qiulian
• Qiu, Zhixin
• Prager, Briana C
• Wang, Xiuxing
• Kim, Leo J Y
• Morton, Andrew R
• Dixit, Deobrat
• Zhou, Wenchao
• Huang, Haidong
• Li, Bin
• Zhu, Zhe
• Bao, Shideng
• Mack, Stephen C
• Chavez, Lukas
• Kay, Steve A
• Rich, Jeremy N

Titel

Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock

Ist Teil von

• Cancer discovery, 2019-11, Vol.9 (11), p.1556-1573

Ort / Verlag

United States

Erscheinungsjahr

2019

Quelle

EZB-FREE-00999 freely available EZB journals

Beschreibungen/Notizen

• Glioblastomas are highly lethal cancers, containing self-renewing glioblastoma stem cells (GSC). Here, we show that GSCs, differentiated glioblastoma cells (DGC), and nonmalignant brain cultures all displayed robust circadian rhythms, yet GSCs alone displayed exquisite dependence on core clock transcription factors, BMAL1 and CLOCK, for optimal cell growth. Downregulation of or in GSCs induced cell-cycle arrest and apoptosis. Chromatin immunoprecipitation revealed that BMAL1 preferentially bound metabolic genes and was associated with active chromatin regions in GSCs compared with neural stem cells. Targeting or attenuated mitochondrial metabolic function and reduced expression of tricarboxylic acid cycle enzymes. Small-molecule agonists of two independent BMAL1-CLOCK negative regulators, the cryptochromes and REV-ERBs, downregulated stem cell factors and reduced GSC growth. Combination of cryptochrome and REV-ERB agonists induced synergistic antitumor efficacy. Collectively, these findings show that GSCs co-opt circadian regulators beyond canonical circadian circuitry to promote stemness maintenance and metabolism, offering novel therapeutic paradigms. SIGNIFICANCE: Cancer stem cells are highly malignant tumor-cell populations. We demonstrate that GSCs selectively depend on circadian regulators, with increased binding of the regulators in active chromatin regions promoting tumor metabolism. Supporting clinical relevance, pharmacologic targeting of circadian networks specifically disrupted cancer stem cell growth and self-renewal. .